The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
Quality tools: Resources for Quality Control Specialists in Medical Writing
Read More
white-paper
The New Chemistry, Manufacturing, and Controls (CMC) Regulations in China
Read More
post
Why FDA PreCheck is a game-changer for small & mid-sized pharma — and how these companies should lean in
Read More
white-paper
Solid-Phase Oligonucleotide Synthesis (SPOS) and Liquid-Phase Oligonucleotide Synthesis (LPOS): Complementary or Competitive Processes?
Read More
Let's move from science to success.
Let’s Talk